Add BrightSurf on Google Email

A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma

A Chinese medicine compound, delisheng, has shown satisfactory anti-cancer effects on hepatocellular carcinoma cells in a three-dimensional cell culture model. The compound's ginseng component is believed to be responsible for its anti-tumor activity, which may lead to new treatment options for HCC patients.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 13, 2007

Electroacupuncture at PC6 may decrease frequency of transient lower esophageal sphincter relaxation

A study published in the World Journal of Gastroenterology found that electroacupuncture at PC6 can decrease the frequency of transient lower esophageal sphincter relaxation (TLESR) induced by gastric distention in cats. The effect appears to act at the brain stem, mediated through nitric oxide (NO), CCK-A, and mu-opioid receptors.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 10, 2007

Can liver cirrhosis be partially cured?

Researchers found that prolonged antiviral therapy can improve residual liver function and reduce portal hypertension in patients with compensated hepatitis C virus-related cirrhosis. The study, published in the World Journal of Gastroenterology, suggests that this treatment approach may delay complications and prolong survival rates.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 10, 2007

Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry

The study found that transcutaneous cervical esophageal ultrasound (TCEUS) is not a substitute for 24-hour pH monitoring or manometry in diagnosing gastroesophageal reflux disease (GERD) and esophageal motor disorders. TCEUS can aid in estimating GER and motility disorders, but it cannot replace these established diagnostic methods.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 9, 2007

Noninvasive tests for cirrhosis may help to avoid liver biopsy

Researchers have found promising results with three new non-invasive imaging tests that can diagnose fibrosis and cirrhosis of the liver without a biopsy. Ultrasound-based transient elastography was accurate in identifying patients with cirrhosis, while MR elastography showed nearly 100% accuracy in detecting any degree of liver fibrosis.

SourceElsevier·JournalClinical Gastroenterology and Hepatology·DateOct 1, 2007

Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer

A study published in Clinical Gastroenterology and Hepatology found that stool DNA testing can detect colorectal cancer with 88% accuracy, regardless of its stage or location. This non-invasive screening test offers a patient-friendly alternative to traditional colonoscopy.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalClinical Gastroenterology and Hepatology·DateDec 13, 2006

African Americans have lower response rate to standard therapy for hepatitis C

A study found that African Americans with hepatitis C infection experience a lower response rate to peginterferon alfa-2a and ribavirin combination treatment compared to Caucasian Americans. The racial difference in viral responses was seen as early as the fourth week of treatment, with African Americans having a significantly lower su...

SourceAmerican Gastroenterological Association·JournalGASTROENTEROLOGY·DateAug 16, 2006

Studies report findings on colorectal cancer screening methods and survival rates

Regular screening significantly reduces cancer deaths in families with hereditary Lynch syndrome, with a 70% decrease in mortality rates. Additionally, research finds that people with IBD-related CRC have similar prognoses as the general population, while a self-propelling colonoscope shows promise in efficient and safe detection.

SourceAmerican Gastroenterological Association·JournalGASTROENTEROLOGY·DateMar 1, 2006

Most chronic hepatitis C sufferers will develop cirrhosis in later life

A recent study published by the American Gastroenterological Association found that nearly 80% of Asian patients with chronic HCV developed cirrhosis after 60 years of infection. The study's results confirm that fibrosis progression is the same across ethnic groups, leading to cirrhosis and liver disease at a similar rate in everyone.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateSep 1, 2005